Cardiovascular and renal action of platelet-activating factor in anesthetized dogs.
Platelet-activating factor (PAF) has hypotensive effects similar to those of antihypertensive polar renomedullary lipid (APRL), a potent endogenous hypotensive lipid. In this study the cardiovascular and renal effects of PAF were characterized in anesthetized dogs. Intravenous infusion of PAF at 0.1 micrograms/kg/min for 1 hour caused marked reduction in arterial blood pressure and cardiac output and was accompanied by minimal changes in heart rate. Concomitantly, renal blood flow, glomerular filtration rate, urine flow, and fractional excretion of Na+ and K+ fell significantly. Plasma renin activity was greatly stimulated (11.9 +/- 1.66 vs 3.26 +/- 0.45 ng/angiotensin I/ml/hr for the placebo group). There were no significant alterations in any of these parameters following PAF at a lower dose (0.03 micrograms/kg/min for 1 hour). In a separate study, PAF at 0.1 micrograms/kg/min for 20 minutes produced a decrease in left ventricular myocardial contractile force, concomitant with bradycardia and hypotension, which indicated the presence of a negative inotropic activity. It is concluded that systemic administration of PAF has a deleterious effect on kidney function due to arterial hypotension and diminished cardiac output.
D000768:Anesthesia, General; D000818:Animals; D002320:Cardiovascular Physiological Phenomena; D004285:Dogs; D005260:Female; D006439:Hemodynamics; D007668:Kidney / Q000502:physiology*; D008297:Male; D009200:Myocardial Contraction; D010972:Platelet Activating Factor / Q000502:physiology*; D012079:Renal Circulation; D012083:Renin / Q000097:blood
D010972:Platelet Activating Factor; D012083:Renin